Gilead Sciences Files Q1 2025 10-Q Report

Ticker: GILD · Form: 10-Q · Filed: May 7, 2025 · CIK: 882095

Gilead Sciences, INC. 10-Q Filing Summary
FieldDetail
CompanyGilead Sciences, INC. (GILD)
Form Type10-Q
Filed DateMay 7, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, financials

TL;DR

Gilead dropped its Q1 2025 10-Q. Check financials.

AI Summary

Gilead Sciences, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and business segments are presented, reflecting the company's ongoing activities in the biopharmaceutical sector.

Why It Matters

This report provides investors and analysts with the latest financial and operational details from Gilead Sciences, crucial for understanding the company's performance and future outlook.

Risk Assessment

Risk Level: low — This is a routine quarterly filing providing financial updates, not indicating any immediate or significant new risks.

Key Numbers

Key Players & Entities

FAQ

What is the reporting period for this 10-Q filing?

The reporting period for this 10-Q filing is the quarter ended March 31, 2025.

When was this 10-Q report filed with the SEC?

This 10-Q report was filed on May 7, 2025.

What is the company's primary business address?

The company's primary business address is 333 Lakeside Dr, Foster City, CA 94404.

What is the fiscal year end for Gilead Sciences, Inc.?

The fiscal year end for Gilead Sciences, Inc. is December 31.

What is the SIC code for Gilead Sciences, Inc.?

The Standard Industrial Classification (SIC) code for Gilead Sciences, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding GILEAD SCIENCES, INC. (GILD).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing